Edmond de Rothschild (Europe)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$2.03M Buy
63,171
+1,133
+2% +$37.9K 0.82% 30
2016
Q2
$2.07M Sell
62,038
-2,350
-4% -$75K 1.04% 20
2016
Q1
$1.81M Sell
64,388
-917
-1% -$26.2K 0.94% 27
2015
Q4
$2M Sell
65,305
-1,265
-2% -$39.8K 0.86% 31
2015
Q3
$1.98M Buy
66,570
+531
+0.8% +$17K 0.92% 29
2015
Q2
$2.1M Buy
+66,039
New +$2.15M 0.67% 40

Other funds holding PFE

Edmond de Rothschild (Europe)'s PFE Position: Q3 2016 in Review

Edmond de Rothschild (Europe) increased its Pfizer (PFE) stake by 1.8% in Q3 2016, buying an estimated $37.9K and bringing the position to 63,171 shares worth $2.03M. The position accounts for 0.82% of the portfolio, ranked #30.

Edmond de Rothschild (Europe) first reported a position in PFE in Q2 2015 and has held it in 6 quarters since. The position peaked at $2.1M in Q2 2015. 1,963 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Edmond de Rothschild (Europe) held 63,171 shares of Pfizer worth $2.03M as of Q3 2016.
  • Edmond de Rothschild (Europe) bought 1,133 Pfizer shares in Q3 2016, an estimated $37.9K.
  • Pfizer made up 0.82% of Edmond de Rothschild (Europe)'s portfolio in Q3 2016, its #30 holding.
  • Edmond de Rothschild (Europe) first reported a position in Pfizer in Q2 2015 and has held it in 6 quarters since.
  • Edmond de Rothschild (Europe)'s Pfizer position peaked at $2.1M in Q2 2015.
  • 1,963 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Edmond de Rothschild (Europe)'s 13F filing for Q3 2016, filed 14 Nov 2016.